These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 21523337

  • 1. Coexistence of inversion 16 and the Philadelphia chromosome comprising P190 BCR/ABL in chronic myeloid leukemia blast crisis.
    Ninomiya S, Kanemura N, Tsurumi H, Kasahara S, Hara T, Yamada T, Moriwaki H.
    Int J Hematol; 2011 Jun; 93(6):806-810. PubMed ID: 21523337
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.
    Neviani P, Santhanam R, Oaks JJ, Eiring AM, Notari M, Blaser BW, Liu S, Trotta R, Muthusamy N, Gambacorti-Passerini C, Druker BJ, Cortes J, Marcucci G, Chen CS, Verrills NM, Roy DC, Caligiuri MA, Bloomfield CD, Byrd JC, Perrotti D.
    J Clin Invest; 2007 Sep; 117(9):2408-21. PubMed ID: 17717597
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The spectrum of adult B-lymphoid leukemias with BCR-ABL: molecular diagnostic, cytogenetic, and clinical laboratory perspectives.
    Klco JM, Kreisel FH, Zehnbauer BA, Kulkarni S, Hassan A, Frater JL.
    Am J Hematol; 2008 Dec; 83(12):901-7. PubMed ID: 18932238
    [Abstract] [Full Text] [Related]

  • 9. [Research advance on molecular genetics of CML blast crisis].
    Zhu HQ, Zhang S, Liu XL.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):217-21. PubMed ID: 18315935
    [Abstract] [Full Text] [Related]

  • 10. BCR/ABL amplification in chronic myelocytic leukemia blast crisis following imatinib mesylate administration.
    Campbell LJ, Patsouris C, Rayeroux KC, Somana K, Januszewicz EH, Szer J.
    Cancer Genet Cytogenet; 2002 Nov; 139(1):30-3. PubMed ID: 12547154
    [Abstract] [Full Text] [Related]

  • 11. bcr/abl mRNA in leukemic blasts of an unusual patient with acute lymphoblastic leukemia followed after 5-year remission by chronic myelogenous leukemia in blast crisis.
    Fujie H, Tsuchiya S, Morita S, Itano M, Yambe T, Ohasi Y, Minegishi N, Minegishi M, Satou T, Konno T.
    Leukemia; 1994 Sep; 8(9):1592-5. PubMed ID: 8090037
    [Abstract] [Full Text] [Related]

  • 12. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS, Lee YS, Yun YS, Kim YR, Jeong SS, Lee YK, She CJ, Yoon SS, Shin HR, Kim Y, Cho HI.
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Successful treatment of lymphoid blastic crisis in chronic myelogenous leukemia with the additional bcr/abl transcript using imatinib-combined chemotherapy and high-dose chemotherapy with allogeneic bone marrow stem cell transplantation.
    Kawano N, Okuda S, Yoshida S, Kugimiya H, Ito M, Horikawa N, Chosa N, Hisakata T, Fukudome T, Sakurai R, Yamashita K, Ueda A, Kanda Y.
    Int J Hematol; 2011 Dec; 94(6):561-6. PubMed ID: 22057509
    [Abstract] [Full Text] [Related]

  • 15. T-cell blast crisis of chronic myelogenous leukemia presented with coexisting p210 and p190 BCR-ABL transcripts and t(10;11)(q11;p15).
    Xia T, Yang Y, Li G, Chang J, Li J, Ren F, Ren W, Wang H, Xu Z.
    J Clin Lab Anal; 2020 Jun; 34(6):e23241. PubMed ID: 32052899
    [Abstract] [Full Text] [Related]

  • 16. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
    Phan CL, Megat Baharuddin PJ, Chin LP, Zakaria Z, Yegappan S, Sathar J, Tan SM, Purushothaman V, Chang KM.
    Cancer Genet Cytogenet; 2008 Jan 01; 180(1):60-4. PubMed ID: 18068536
    [Abstract] [Full Text] [Related]

  • 17. Acquired loss of p53 induces blastic transformation in p210(bcr/abl)-expressing hematopoietic cells: a transgenic study for blast crisis of human CML.
    Honda H, Ushijima T, Wakazono K, Oda H, Tanaka Y, Aizawa Si, Ishikawa T, Yazaki Y, Hirai H.
    Blood; 2000 Feb 15; 95(4):1144-50. PubMed ID: 10666183
    [Abstract] [Full Text] [Related]

  • 18. Extramedullary presentation of chronic myelogenous leukemia with p190 BCR/ABL transcripts.
    Yamaguchi H, Inokuchi K, Shinohara T, Dan K.
    Cancer Genet Cytogenet; 1998 Apr 01; 102(1):74-7. PubMed ID: 9530344
    [Abstract] [Full Text] [Related]

  • 19. Inversion of chromosome 16 in accelerated phase of chronic myeloid leukaemia: report of a case and review of the literature.
    Colović M, Janković G, Bila J, Djordjević V, Wiernik PH.
    Med Oncol; 1998 Sep 01; 15(3):199-201. PubMed ID: 9819797
    [Abstract] [Full Text] [Related]

  • 20. An inv(16) in Ph-negative cells of a chronic myelogenous leukemia patient after imatinib treatment.
    Rowe LR, Brothman AR, Nibley WE, Gaffney MR, Chen Z.
    Cancer Genet Cytogenet; 2007 Apr 01; 174(1):54-6. PubMed ID: 17350467
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.